It has recently been suggested that first ray amputation in diabetic patients with serious foot complications can prolong bipedal ambulatory status, and reduce morbidity and mortality. However, no data are available on gait analysis and quality of life after this procedure. In the present case-control study (6 amputee and 6 nonamputee diabetics, 6 healthy non-diabetic), a sample of amputee diabetic patients were evaluated and compared with a sample of nonamputee diabetic patients and a group of agematched healthy subjects. Gait biomechanics, quality of life, and pain were evaluated. Compared with the other 2 groups, amputee patients displayed a lower walking speed and greater variability and lower ankle, knee, and hip range of motion values. They also tended to have a more flexed hip profile. Pain and lower quality of life were related to worsening biomechanical data. Our study results have shown that gait biomechanics in diabetic patients with first ray amputation are abnormal, probably owing to the severity of diabetes and the absence of the push-off phase provided by the hallux. Tailored orthotics and rehabilitation programs and a specific pain management program should be considered to improve the gait and quality of life of diabetic patients with first ray amputation.
an increased risk of falls and a greater likelihood of developing a foot ulcer.
Regarding the biomechanical studies on kinematic gait changes in diabetic patients with neuropathy, contrasting results have been reported. A study conducted by Paul et al (14) , in which diabetic patients with neuropathy were compared with those without neuropathy, detected differences in gait parameters (i.e., neuropathic subjects walked more slowly and took smaller steps). Similarly, longer double and single stance times, lower minimum vertical force, and lower growth rates were seen in the neuropathic patients compared with the diabetic and nondiabetic subjects (15) . In contrast, Yavuzer et al (16) found slower gait, shorter steps, and limited knee and ankle mobility in patients without neuropathy, but not in those with neuropathy, compared with healthy subjects.
Some studies have investigated the kinematic gait changes in diabetic patients who have undergone amputation. Walking limitations depend on the level of the amputation. Major amputations will result in significant functional impairment associated with the increase in the physical effort required to maintain walking ability (14) . Partial foot amputations, such as transmetatarsal amputations or forefoot amputations, have less effect on a patient's walking ability (15) .
Few data are available on gait analysis in patients with forefoot amputations. Transmetatarsal amputation not only preserves ankle function and maintains a distal weightbearing surface but also ensures a more energy-efficient gait (17) compared with more proximal amputations. The latter result in compromised foot and ankle propulsive function and, consequently, in transfer of the primary role of power for walking from the ankle to the hip (5, (17) (18) (19) .
No studies have yet been conducted on the kinematic gait changes in patients who have undergone first ray amputation (FRA), defined as amputation of the phalanxes and at least part of the metatarsus (20) . This surgical technique was recently proposed as a procedure that can save the foot, prolong the patient's bipedal ambulatory status, and reduce the patient's morbidity and mortality (21) .
Abnormal gait can negatively affect quality of life (QoL) and has been observed in a range of pathologies (22) . A significant worsening occurs in the QoL of diabetic patients (23) in relation to peripheral nerve damage (24) . However, no studies have yet investigated the relationship between quantitative gait parameters and QoL in diabetic patients.
The aim of the present study was to investigate whether diabetic patients with FRA adopt different walking strategies from either nonamputee diabetic patients or healthy subjects. Pain and QoL were evaluated to analyze possible differences between amputee and nonamputee diabetic patients and to evaluate any correlation between these patient-oriented subjective tools and the objective gait data.
Patients and Methods

Participants
Our study should be considered a pilot study conducted for exploratory data analysis purposes. We enrolled 6 male diabetic subjects with unilateral FRA, the amputee diabetic patient (ADP) group (mean age 75, range 60 to 90 years; disease duration since diagnosis, mean ± standard deviation 16 ± 6.6 years); 6 diabetic patients without FRA, the diabetic patient (DP) group (2 females, 4 males; mean age 68.16, range 65 to 73 years; disease duration since diagnosis, mean 13 ± 7.6 years); and 6 healthy subjects, the healthy subject (HS) group (4 females, 2 males; mean age 67.5, range 64 to 73 years). The inclusion criteria were type 2 diabetes mellitus (with or without diabetic neuropathy) and the ability to walk independently without assistance or walking aids. The exclusion criteria were a history of previous amputation, cognitive or visual impairment, cardiac diseases (which could reduce safety when walking), and other diseases liable to cause motor gait impairment (e.g., radiculopathy and fractures). The diagnosis of peripheral neuropathy was defined as a neuropathy disability score >5 (25) and pathologic nerve conduction velocity findings. Self-reported data (using QoL and pain standardized measures) were collected, and an objective gait evaluation was performed of all 18 subjects. All the participants gave written informed consent before inclusion in the study, which complied with the Declaration of Helsinki. The ethics committee of the Don Carlo Gnocchi Onlus Foundation approved the experimental protocol, which was explained, together with the aims of the research, to the subjects involved in the study.
QoL and Pain Assessment
The QoL assessment was performed using the Short-Form 36-item Health Survey (SF-36) and North American Spine Society (NASS) questionnaire. Pain was evaluated using the numeric rating scale (NRS), ID-Pain, and the Neuropathic Pain Symptom Inventory (NPSI). The official Italian version of the SF-36 (26) consists of 36 questions that cover the general health of patients. It contains 10 specific categories of physical and emotional domains. The scores for each category range from 0 to 100, with very low values corresponding to severe physical impairment or emotional discomfort. The NASS, which is used to analyze neurologic symptoms and lower limb function, yields 2 scores: lumbar spine pain/disability (NASS-P) and lumbar spine neurogenic symptoms (NASS-L). The score for each category ranges from 0 to 100, with higher scores indicating better health (27) . The NRS (range 0 to 10) measures the intensity of pain, with the score ranging from 0 (no pain) to 10 (the worst imaginable pain) (28, 29) . IDPain is a 6-item self-administered questionnaire developed by Portenoy (30) to discriminate neuropathic from nociceptive pain. The NPSI is a self-administered questionnaire designed to evaluate various symptoms of neuropathic pain. Each item is quantified on a numeric scale (range 0 to 10). The final version of the NPSI contains 12 items: 10 that describe the different symptoms and 2 that assess the duration of spontaneous ongoing and paroxysmal pain. A total intensity score can be calculated by summing the scores of the 12 items (31).
Gait Analysis
The gait analysis was performed using the Smart D500 stereophotogrammetric system (BTS Bioengineering, Milan, Italy). The system consists of 8 infrared cameras (sampling rate of 250 Hz) to acquire movement of the reflective spherical markers placed over anatomic landmarks. The subjects were equipped with 22 retroreflective markers, according to the Davis protocol (32) . The markers were placed on the following anatomic landmarks: seventh cervical vertebra, right and left acromioclavicular joint, right and left anterior superior iliac spine, sacrum, right and left greater trochanter, right and left mid-thigh, right and left lateral femur condyle, right and left fibular head, right and left mid-shank, right and left lateral malleolus, right and left fifth metatarsal head, and right and left heel. Anthropometric data were collected for each subject (33) . Before formal measurements were started, practice sessions were performed to familiarize the participants with the procedure. They were trained to walk barefoot (without shoes for nonamputee patients and without toe filler for amputee patients) straight ahead along a level surface that was approximately 6-m long. Both diabetic and healthy subjects were asked to walk at a comfortable self-selected speed. Ten linear walking trials were acquired for each subject. To avoid fatigue, groups of 5 trials were separated by a 1-minute rest.
Data Analysis
Three-dimensional marker trajectories were tracked using a frame-by-frame tracking system (Smart Tracker-BTS, Milan, Italy). Data were processed using 3-dimensional reconstruction software (SMARTAnalyzer, BTS, Milan, Italy) and MATLAB, version 7.4.0, software (MathWorks, Natick, MA). The gait cycle duration was defined as the interval between 2 consecutive heel contacts of the same foot. The following spatiotemporal parameters were calculated: stance, percentage of duration of the swing and double support phases, cadence, step length, and step width. For all spatiotemporal parameters, the coefficient of variation was calculated as the ratio between the standard deviation and the mean value for each subject. To evaluate the asymmetry and bilateral coordination of gait, the spatial asymmetry index (SAI; Eq. 1) and temporal asymmetry index (TAI; Eq. 2) were calculated for the ADP group as follows (34):
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For the DP and HS groups, the SAI and TAI were computed according to HodtBillington et al (35) , using the lower and higher values of the step length and single support time, respectively. Higher absolute SAI and TAI values indicate greater asymmetry, and perfect symmetry in the spatiotemporal parameters corresponds to an SAI and a TAI of 0.
To assess the lower limb joint kinematics on the sagittal plane, we calculated the hip, knee, and ankle joint angular displacements and their range of motion (ROM). Specifically, we considered the amputated and nonamputated side for the ADP group separately; for the DP and HS groups, we averaged the data between the right and left sides.
Statistical Analysis
Statistical analysis was performed using the StatSoft (Statistica, Tulsa, OK) package. Owing to the small sample size, nonparametric analyses were performed. To determine the clinical differences between the 2 patient groups, the Mann-Whitney U test was used for continuous variables and the Fisher exact test for categorical variables. The Kruskal-Wallis test was used to determine differences between the groups for all the variables investigated. When the test was positive, we performed the MannWhitney U test to determine exactly where the differences between groups lay. Moreover, we used Spearman's rank correlation coefficient test to evaluate the correlations between the gait spatiotemporal parameters and joint ROMs and the results from the ID-Pain, NRS, NPSI, SF-36 bodily pain, SF-36 physical composite score, SF-36 mental composite score, NASS-L, and NASS-P questionnaires. The level of significance for all parameters was set at p ≤ .05. All the tests should be considered exploratory because no previous power calculation or subsequent corrections for multiple testing were applied.
Results
Sample
The clinical features, anthropometric aspects, and diabetic comorbidities in the ADP and DP groups are listed in Table 1 . None of the DPs had ulcers. No statistically significant differences between the 2 groups were observed in age, disease duration, body mass index, height, history of lower extremity arterial occlusive disease, or history of acute myocardial infarction. Moreover, age, body mass index, and height were not statistically significantly different neither between the ADP and HS groups, nor between the DP and HS groups.
QoL and Pain
A comparison of the ADP and DP groups showed statistically significant differences for most of the SF-36, NASS, and NPSI items ( Table  2 ). In particular, the ADP group yielded lower values (i.e., worse QoL) than those of the DP group for SF-36 physical function (p < .01), SF-36 role physical (p < .05), SF-36 bodily pain (p < .01), SF-36 social function (p < .01), and SF-36 physical composite score (p < .01). Moreover, the NASS-P scores were significantly lower (i.e., worse pain) in the ADP group than in the DP group (p < .01). Finally, the NPSIpressing (deep) spontaneous pain (p < .01), NPSI-evoked pain (p < .05), NPSI-paresthesia/dysesthesia (p < .05), and NPSI total score (p < .01) yielded higher scores (i.e., greater neuropathic pain) for the ADP group than for the DP group.
Gait Analysis: Spatiotemporal Parameters
Significant differences in mean speed were observed between the ADP and DP groups (p < .05) and between the ADP and HS groups (p < .05), although not between the DP and HS groups (Fig. 1) . Because no significant differences emerged in the ADP group for any of the spatiotemporal data between the amputated and nonamputated sides, we only considered the data from the amputated side. The main spatiotemporal parameters (percentage of stance, percentage of swing, percentage of double support, cadence, step length, and step width) in the ADP (amputated side), DP, and HS (mean value between lower limbs) groups are shown in Fig. 2 . Significant differences were observed in step length and step width between the ADP and DP groups (step length, p < .01; step width, p < .01) and between the ADP and HS groups (step length, p < .01; step width, p < .01), with a shorter step length and larger step width detected in the ADP group compared with the DP and HS groups. In contrast, no statistically significant differences were found between the DP and HS groups. The coefficient of variation of the spatiotemporal parameters is shown in Fig. 3 . A significantly greater coefficient of variation was observed for the ADP group than for the DP group in the duration of the swing phase (p < .01) and step length (p < .05). A significantly greater coefficient of variation was also observed for the ADP group compared with the HS group in the duration of the swing phase (p < .05) and step length (p < .01). Finally, no significant differences among the 3 groups were observed in the SAI and TAI (Fig. 4) .
Gait Analysis: Joint Kinematics
The peak value of the angular displacement, ROM for the ankle, knee, and hip joints, and statistical analysis results are listed in Table 3 . In the ADP group, no significant differences emerged for any of the kinematic data between the amputated and nonamputated sides; therefore, we only considered data from the amputated side. The mean hip, knee, and ankle joint kinematics for the 3 groups are shown in Fig. 5 . The hip joint extension profile was remarkably shorter (Fig. 5) in the ADP group than in either the DP or HS group, which was confirmed by the significant reduction in the hip extension peak (p < .01 for both ADP versus DP and ADP versus HS). The hip joint ROM was also reduced in the ADP group compared with the DP and HS groups (although without reaching statistical significance). Hip joint kinematic behavior in the DP group was normal, with no significant difference in hip ROM detected between the DP and HS groups. The knee flexion peak in the swing phase was lower in the ADP group than in the other 2 groups (Fig. 5) . The reduction observed in ROM (p < .05) and difference in the knee flexion peak (p < .05) was significant between the ADP group and the HS group, although not between the ADP group and the DP group. A greater The box shows the interquartile range (25th to 75th percentile); the horizontal line box indicates the median; and the vertical bars, the range of observations. * Statistically significant difference (p < .05). ADP, amputee diabetic patient (n = 6); DP, diabetic patient (n = 6); HS, healthy subject (n = 6). .01) . ADP, amputee diabetic patient (n = 6); DP, diabetic patient (n = 6); HS, healthy subject (n = 6). difference emerged in the ankle joint, with the ADP group displaying lower levels of dorsiflexion and plantarflexion. A qualitative analysis of the plot (Fig. 5 ) revealed a marked reduction in plantarflexion during push-off in the ADP group, which was confirmed by the significantly lower ankle ROM (p < .05) in the ADP group compared with the HS group.
Correlations Between Pain and QoL and Biomechanical Parameters
The correlation analysis between the gait parameters and pain revealed that the NPSI scores correlated positively with step width (r = 0.64; p < .05) and negatively with step length (r = −0.67; p < .05), knee ROM (r = −0.78; p < .01), ankle ROM (r = −0.77; p < .01), and knee Statistically significant difference at p < .01. ADP, amputee diabetic patient (n = 6); DP, diabetic patient (n = 6); HS, healthy subject (n = 6). to 75th percentile) ; the horizontal line indicates the median; and the vertical bars, the range of observations excluding outliers (circles) and extremes (stars). Outliers are observations >1.5 box lengths from the box; extremes are >3 box lengths from the box. ADP, amputee diabetic patient (n = 6); DP, diabetic patient (n = 6); HS, healthy subject (n = 6).
flexion peak (r = −0.70; p < .05). Pain measured using the SF-36 bodily pain subscale also correlated negatively with step length (r = −0.71; p < .01) and positively with step width (r = 0.70; p < .05). For the QoL measures, the SF-36 physical composite score correlated positively with step length (r = 0.76; p < .01), hip ROM (r = 0.61; p < .05), knee ROM (r = 0.77; p < .01), and knee flexion peak (r = 0.72; p < .01) and negatively with step width (r = −0.75; p < .01) and hip extension peak (r = −0.68; p < .05). The SF-36 mental composite score correlated positively with the ankle dorsiflexion peak (r = 0.61; p < .05). NASS-L correlated positively with step length (r = 0.59; p < .05) and knee flexion peak (r = 0.59; p < .05) and negatively with step width (r = −0.69; p < .05). NASS-P correlated positively with step length (r = 0.70; p < .05), knee ROM (r = 0.72; p < .01), ankle ROM (r = 0.65; p < .05), and knee flexion peak (r = 0.69; p < .05) and negatively with step width (r = −0.74; p < .01) and hip extension peak (r = −0.60; p < .05).
Discussion
In the present study, we investigated 3-dimensional lower limb kinematics in patients with diabetes and FRA. To gain a more thorough understanding of the biomechanical data from such patients, we also evaluated pain and QoL using validated tools. The ADPs exhibited a shorter step length, a larger step width, and a slower walking speed than either the DP or HS group. The ADP group also displayed a greater variability in step length and duration of the swing phase. We did not observe any significant differences in walking speed between the DP and HS group, in keeping with the findings from Rao et al (36) . Regarding the biomechanical data, the only significant difference between the ADP and DP groups was in the hip extension peak. In contrast, significant differences were found between the ADP and HS groups for ankle ROM, knee ROM, knee flexion peak, and hip extension peak. However, the angular trajectories of the hip, knee, and ankle joints shown in Fig. 5 clearly indicate that marked differences were present, not only between the ADP and HS groups, but also between the ADP and DP groups. The joint angular trajectories of the DP group were always within the range of healthy subjects, but those of the ADP group were largely outside the control range for a considerable portion of the gait cycle. That such marked deviations did not result in statistically significant differences in the numeric parameters was likely because of the limited sample size and the marked degree of intersubject variability within the ADP group, as demonstrated by the standard deviation of the kinematic parameters of that group, which were 2 and even 3 times greater than those for either the DP or HS group (Table 3) . The joint kinematic pattern of the amputated side did not differ from that of the nonamputated side (Fig. 5 ) in the ADPs, as confirmed by the very similar kinematic values for both sides (Table 3) . (17) compared transmetatarsal amputee subjects with a control group, they found that the ROM, peak moments, and peak power at the ankle and the ROM at the hip were lower in the amputee subjects than in the controls. They hypothesized that because those who undergo transmetatarsal amputation have a reduced ability to generate plantarflexor power at the ankle, they rely more heavily on "pulling" their leg forward from the hip using their hip flexor muscles (17) . The kinematic parameters at the hip and ankle in our subjects were similar and, as expected, so was the involvement of the knee joint. This finding suggests that FRA modifies the kinematic behavior of all the lower limb joints. Unlike the results from Mueller et al (17) , our biomechanical data were obtained from subjects who walked barefoot (without shoes or, in amputees, without a toe filler) to ascertain the true effect of a missing first ray on gait.
When Mueller et al
It is noteworthy that no differences were detected in the ADP group for any of the spatiotemporal data between the amputated and nonamputated sides; accordingly, no differences were found among the 3 groups in the SAI and TAI parameters. This finding might be correlated with the lower level of amputation. However, because significant abnormalities were symmetrically present in the ADP group (Fig. 5) , an alternative explanation might be that the effects of neuropathy, which is bilateral, prevailed over those of the monolateral amputation. Yet another possible explanation is that the ADP group adopted a compensatory strategy on the intact side to limit the asymmetries arising on the amputated side.
Although FRA seems to affect gait less than a more proximal amputation, at least with respect to asymmetry of the gait, published studies have reported that patients who undergo partial FRA often progress to requiring a more proximal repeat amputation (37) . We believe that the risk of new ulceration, resulting in a new amputation, will be greater for those undergoing FRA rather than a more proximal amputation owing to the better weightbearing with the latter. In patients with diabetes, abnormal plantar pressure is one of the factors leading to the development of plantar foot ulcers, and ulcers are a precursor to amputation (38, 39) . Thus, it is important to reduce the plantar pressure in these patients (e.g., using a shoe with a total contact insole) to reduce the likelihood of reamputation (40) . A recent meta-analysis (41) reported a high occurrence of more proximal amputation after transmetatarsal amputation, suggesting that the choice between the latter or other minor amputations should be tailored to the patient. For example, according to Oliver et al (42) , hallux rigidus seems to be a predisposing factor for reamputation after FRA.
Regarding QoL and pain, our results have shown that the QoL concerning physical aspects and pain was worse in the ADP group than in the DP group. In particular, the pain measures we adopted showed that the ADPs complained of neuropathic pain symptoms more often than did the DPs. One possible reason for this finding is that diabetic neuropathy affects 50% of ADPs but only 1 in 6 of DPs. The significant correlation between QoL and pain and the biomechanical data suggests that the abnormal gait performance in the ADPs might result, not only from the missing first ray, but also from more severe neuropathic pain. Our findings further support the progressive nature of chronic complications associated with diabetes and the consequent greater risk of biomechanical worsening as the severity of neuropathy increases (6).
The potential limitations of our study were the small sample size and the lack of kinetic gait data and speed-matched controls (because of very low subject compliance, which decreased further because they were asked to walk barefoot).
In conclusion, our results have showed that, although less invasive than other surgical treatments, FRA negatively affects the gait strategies in patients with diabetes. Moreover, we found that in our amputated patients neuropathic pain was increased and QoL was deteriorated compared with those of our diabetic patients without amputation. Therefore, specific gait rehabilitation treatment Fig. 5 . Hip, knee, and ankle joint kinematic for the 3 groups. Each curve represents the average of trials and subjects for each group. The curve for the healthy subject (HS) group (n = 6) was associated with ±1 standard deviation range. ADP, amputee diabetic patient (n = 6); DP, diabetic patient (n = 6). Statistical analysis showed a reduction in the hip extension peak (p < .01) in ADP when compared both with DP and HS, a reduction in the knee flexion peak (p < .05) in ADP when compared with HS, and, finally, a reduction in ankle ROM (p < .05) in ADP, when compared with HS. and orthotics should be studied and more attention should be given to pain management to improve the QoL of patients who undergo FRA.
